ライフサイエンスコーパス: yellow fever virus

1 us, Murray Valley virus, Powassan virus, and yellow fever virus).

2 , such as dengue virus, West Nile virus, and yellow fever virus.

3 lustered substitutions in the NS1 protein of yellow fever virus.

4 uch as hepatitis C virus, dengue viruses and yellow fever virus.

5 NV), Zika virus (ZIKV), West Nile virus, and yellow fever virus.

6 nd-concomitantly-protective immunity against yellow fever virus.

7 dengue virus (DENV), Zika virus (ZIKV), and yellow fever virus.

8 rica to understand and predict the spread of yellow fever virus.

9 es or West Nile virus, or vaccinated against yellow fever virus.

10 iated mosquito-borne flaviviruses, including yellow fever virus.

11 munodeficiency virus, influenza A virus, and yellow fever virus.

12 s, including pathogens such as influenza and yellow fever virus.

13 nfection and cell death by DENV-2, ZIKV, and yellow fever virus.

14 EN) 4 virus was chimerized with the WT Asibi yellow fever virus.

15 ansmission of dengue, chikungunya, Zika, and yellow fever viruses.

16 ce, including Zika, chikungunya, dengue, and yellow fever viruses.

17 NS4B biogenesis extends to the West Nile and Yellow Fever viruses.

18 hich transmit Zika, chikungunya, dengue, and yellow fever viruses.

19 ain vector of dengue, Zika, chikungunya, and yellow fever viruses.

20 ot neutralize or immune-precipitate mumps or yellow fever viruses.

21 diseases that include West Nile, dengue and yellow fever viruses.

22 of other flaviviruses, including dengue and yellow fever viruses.

23 nction of NS4B is conserved in West Nile and yellow fever viruses.

24 he related mosquito-transmitted flaviviruses yellow fever virus 17D (YFV) and dengue virus type 2 (DE

25 nally track the human B cell response to the yellow fever virus 17D (YFV-17D) vaccine.

26 wing ex vivo exposure to the live attenuated yellow fever virus 17D strain vaccine, a virus that we s

27 s of the flavivirus dengue virus (DV) and by yellow fever virus 17D were cholesterol independent, and

28 ift Valley fever virus, West Nile virus, and yellow fever virus), 8 bacteria (Bartonella spp., Brucel

29 The capsid proteins of two flaviviruses, yellow fever virus and dengue virus, were expressed in E

30 ext of published studies of vaccines against yellow fever virus and influenza virus.

31 , including dengue virus (DENV), Zika virus, yellow fever virus and others.

32 sis of CD8(+) T cells responding to the live yellow fever virus and smallpox vaccines--two highly suc

33 include the 2 flaviviruses dengue virus and yellow fever virus and the alphavirus chikungunya virus,

34 In contrast, yellow fever virus and West Nile virus were partially an

35 ding vesicular stomatitis virus, poliovirus, yellow fever virus, and herpes simplex virus type 1, rep

36 Arboviruses like dengue virus, yellow fever virus, and West Nile virus are enveloped pa

37 ncluding all four serotypes of dengue virus, yellow fever virus, and West Nile virus.

38 vectors of African malaria, dengue fever and yellow fever viruses, and lymphatic filariasis, respecti

39 oflaviviruses, including West Nile virus and yellow fever virus, but not to the broader Flaviviridae

40 ted infectious virion production of ZIKV and yellow fever virus, but not West Nile virus.

41 es from melanoma, CMV, influenza A, EBV, and yellow fever viruses, but they were of low frequency and

42 Yellow fever virus can cause, among other symptoms, hemo

43 ae family, including dengue virus (DENV) and yellow fever virus, cause serious disease in humans, whi

44 y-important viruses, including dengue virus, yellow fever virus, chikungunya virus, and Zika virus, a

45 nd other flaviviruses, such as West Nile and yellow fever viruses, contain a 5' m7GpppN-capped positi

46 curred in NS2B-NS3 recombinant proteins from yellow fever virus, dengue virus types 2 and 4, and Japa

47 ing three members of the family Flaviviridae(yellow fever virus, dengue virus, and bovine viral diarr

48 Flaviviruses, such as Zika virus, yellow fever virus, dengue virus, and West Nile virus (W

49 cutive plaque purifications of four chimeric yellow fever virus-dengue virus (ChimeriVax-DEN) vaccine

50 revaccination or natural infection with wild yellow fever virus during a 2011-12 outbreak in northern

51 rm persistence of neutralising antibodies to yellow fever virus following routine vaccination in infa

52 f 18 nucleotides (residues 146 to 163 of the yellow fever virus genome, which encode amino acids 9 to

53 ucleotide sequence found in the 5' region of yellow fever virus genomic RNA that is required for RNA

54 Yellow fever virus has four basic residues (Arg-Lys-Arg-

55 A vaccine against the prototype flavivirus, yellow fever virus, has been deployed for 85 years and i

56 s such as Zika virus, chikungunya virus, and yellow fever virus have drawn attention toward other coc

57 However, dengue, chikungunya, and yellow fever viruses have repeatedly initiated urban tra

58 ssessed neutralizing antibody titers against yellow fever virus in blood samples obtained before vacc

59 ave caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil.

60 eplication of infectious West Nile virus and yellow fever virus in cell culture with low toxicity.

61 We identified one read from yellow fever virus in cerebrospinal fluid from the recip

62 The data indicate that persistence of yellow fever virus in NB41A3 cells is associated with a

63 g dengue, chikungunya, and Zika viruses, and yellow fever virus in urban settings, pose an escalating

64 tion of Zika, Ebola, dengue, chikungunya and yellow fever viruses in plasma samples from infected pat

65 Two forms of NS2A are found in yellow fever virus-infected cells.

66 ogistic model to infer the district-specific yellow fever virus infection risk during the course of t

67 aviviruses, including West Nile, dengue, and yellow fever viruses, is capable of inducing variable de

68 Vaccine strains of yellow fever virus, isolated from the plasma of two pati

69 ephalitis virus, norovirus, metapneumovirus, yellow fever virus, Japanese encephalitis virus, parainf

70 elp uncover the causes of three outbreaks as yellow fever virus, monkeypox virus, and a noninfectious

71 cokinetics of TY014, a fully human IgG1 anti-yellow fever virus monoclonal antibody.

72 that the E protein is a critical factor for yellow fever virus neuropathogenesis in the SCID mouse m

73 Yellow fever virus neutralizing antibody responses occur

74 Dengue, West Nile, or yellow fever virus NS1 directly associated with C4b bind

75 directed against a conserved immunodominant yellow fever virus NS3 epitope.

76 Structures of prM-containing dengue and yellow fever virus particles were determined to 16 and 2

77 NV), Zika virus (ZIKV), West Nile virus, and yellow fever virus, pose significant public health threa

78 The atomic resolution of yellow fever virus-Powassan virus chimera (yPOWV) struct

79 The past evolution of the dengue and yellow fever viruses provides clues about the influence

80 In contrast, an unrelated flavivirus, yellow fever virus, replicated equally well in uninfecte

81 protein) is essential for replication of the yellow fever virus replicon and that a slightly longer s

82 30451, specifically blocked translation of a yellow fever virus replicon but not a Sindbis virus repl

83 l four organ recipients by identification of yellow fever virus RNA consistent with the 17D vaccine s

84 ed nucleotide and that the error rate of the yellow fever virus RNA polymerase employed by the chimer

85 ly proposed to be involved in cyclization of yellow fever virus RNA.

86 d mosquito-borne flaviviruses, which include yellow fever virus, Sepik virus, Saboya virus, and other

87 wide range of viruses, including DENV, WNV, yellow fever virus, Sindbis virus, Venezuelan equine enc

88 sed analyses of mass cytometry data, we show yellow fever virus-specific cCXCR5 T cells elicited by v

89 o many flavivirus types including Dengue and yellow fever viruses, the nonstructural NS3 multifunctio

90 timated timing, source, and likely routes of yellow fever virus transmission and dispersion during on

91 trative division across countries at risk of yellow fever virus transmission from 1970 to 2016.

92 till require vaccination in areas at risk of yellow fever virus transmission to achieve the 80% popul

93 s constructed from the genetic backbone of a yellow fever virus vaccine strain 17D (YFV-17D) and the

94 This live attenuated yellow fever virus vaccine yields sterile, long-term imm

95 and adverse reactions to the live attenuated yellow fever virus vaccine.

96 The early spread of yellow fever virus was characterised by fast exponential

97 Recent infection with yellow fever virus was confirmed in all four organ recip

98 Using yellow fever virus, we determine that this G4 promotes v

99 Vaccine-related variants of yellow fever virus were found in plasma and cerebrospina

100 ax-II), rotavirus (Rotateq and Rotarix), and yellow fever virus were negative for XMRV and highly rel

101 animal viruses, including hepatitis C virus, yellow fever virus, West Nile virus, chikungunya virus,

102 Binding of yellow fever virus wild-type strains Asibi and French vi

103 The ChimeriVax technology utilizes yellow fever virus (YF) 17D vaccine strain capsid and no

104 ysis of the nonstructural protein 1 (NS1) of yellow fever virus (YF) has implicated it in viral RNA r

105 Nonstructural protein 1 (NS1) of yellow fever virus (YF) is a glycoprotein localized to e

106 y, of bovine viral diarrhea virus (BVDV) and yellow fever virus (YF), members of the other two establ

107 e a high mosquito infectivity phenotype, the yellow fever virus (YFV) 17D backbone of the ChimeriVax-

108 A neuroadapted strain of yellow fever virus (YFV) 17D derived from a multiply mou

109 The live attenuated yellow fever virus (YFV) 17D vaccine provides a good mod

110 f the replication-competent, live-attenuated yellow fever virus (YFV) 17D vaccine provides lifelong i

111 phosphorylation sites of the NS5 proteins of yellow fever virus (YFV) and dengue virus (DENV), two fl

112 Previous studies of yellow fever virus (YFV) and dengue virus have found tha

113 tricts two medically important flaviviruses, yellow fever virus (YFV) and dengue virus serotype 2 (DE

114 ncy extends to the NS4A and NS4B proteins of Yellow Fever virus (YFV) and West Nile virus (WNV), whic

115 Arboviruses such as yellow fever virus (YFV) are transmitted between arthrop

116 out metagenomic sequencing which implicated yellow fever virus (YFV) as the etiology of this outbrea

117 In the present study we characterize the Yellow Fever Virus (YFV) associated with this outbreak i

118 Yellow fever virus (YFV) can induce acute, life-threaten

119 The recent yellow fever virus (YFV) epidemic in Brazil in 2017 and

120 etime recommendation for vaccination against yellow fever virus (YFV) has been controversial, leading

121 The recent reemergence of yellow fever virus (YFV) in Brazil has raised serious co

122 e previously demonstrated to be required for yellow fever virus (YFV) infection and others subsequent

123 Hepatocytes are a major target of yellow fever virus (YFV) infection, and the coagulopathy

124 the considerable morbidity and mortality of yellow fever virus (YFV) infections in Brazil, our under

125 Here we show that yellow fever virus (YFV) inhibits IFN-I signaling throug

126 Yellow fever virus (YFV) is a re-emerging flavivirus tha

127 Yellow fever virus (YFV) is a reemerging global health t

128 Yellow fever virus (YFV) is a zoonotic arbovirus affecti

129 Yellow fever virus (YFV) is the prototype member of the

130 Yellow fever virus (YFV) live attenuated vaccine can, in

131 sequencing is presented using as a model the yellow fever virus (YFV) live vaccine strain 17D-204 and

132 It was previously reported that mutations in yellow fever virus (YFV) nonstructural protein NS2A bloc

133 gue virus (DENV), West Nile virus (WNV), and yellow fever virus (YFV) NS1 attenuate classical and lec

134 Yellow fever virus (YFV) replicates its RNA genome in me

135 verexpressed DNAJC14 is targeted to sites of yellow fever virus (YFV) replication complex (RC) format

136 Here we describe a two-component genome yellow fever virus (YFV) replication system in which eac

137 s-packaging system that involved packaging a yellow fever virus (YFV) replicon into pseudo-infectious

138 dies have demonstrated prolonged presence of yellow fever virus (YFV) RNA in saliva and urine as an a

139 A molecular clone of yellow fever virus (YFV) strain 17D was used to identify

140 safety and immunogenicity of live attenuated yellow fever virus (YFV) vaccination of nonatopic subjec

141 previously demonstrated that live attenuated yellow fever virus (YFV) vaccine (LA-YF-Vax) dampens T-c

142 In this study, we used the live attenuated yellow fever virus (YFV) vaccine 17D as a human in vivo

143 Here we address this issue using the live yellow fever virus (YFV) vaccine, which induces long-ter

144 on in humans using primary immunization with yellow fever virus (YFV) vaccine.

145 Yellow fever virus (YFV), a member of the Flavivirus gen

146 Yellow fever virus (YFV), a mosquito-borne Orthoflavivir

147 ose of tick-borne encephalitis virus (TBEV), yellow fever virus (YFV), and Japanese encephalitis viru

148 viridae family, such as Dengue virus (DENV), Yellow fever virus (YFV), and Zika virus (ZIKV) are noto

149 th threats, including dengue viruses (DENV), yellow fever virus (YFV), and Zika virus (ZIKV).

150 of many important human pathogens including yellow fever virus (YFV), dengue virus (DENV), and Zika

151 that TRIM56 poses a barrier to infections by yellow fever virus (YFV), dengue virus serotype 2 (DENV2

152 low Fever (YF) is a severe disease caused by Yellow Fever Virus (YFV), endemic in some parts of Afric

153 involves the gene-specific amplification of yellow fever virus (YFV), Japanese encephalitis virus (J

154 importance, such as dengue virus (DENV) and yellow fever virus (YFV), originated in sylvatic transmi

155 Infection by yellow fever virus (YFV), the prototype Orthoflavivirus,

156 Using yellow fever virus (YFV), we demonstrate that DNAJC14 re

157 + T cells specific for a single epitope from Yellow Fever Virus (YFV), we show that the recently desc

158 flaviviruses.IMPORTANCE Flaviviruses such as yellow fever virus (YFV), Zika virus (ZIKV), and dengue

159 Mosquito-borne flaviviruses, including yellow fever virus (YFV), Zika virus (ZIKV), and West Ni

160 t Nile virus (WNV), dengue virus (DENV), and yellow fever virus (YFV).

161 ted vaccination against the etiologic agent, yellow fever virus (YFV).

162 a mosquito-borne zoonotic disease caused by yellow fever virus (YFV).

163 ine (BDAA) compound, which potently inhibits yellow fever virus (YFV).

164 izing antibodies for dengue virus (DENV) and yellow fever virus (YFV).

165 Two yellow fever virus (YFV)/dengue virus chimeras which enc

166 A yellow fever virus (YFV)/Japanese encephalitis virus (JE

167 e insights into how a prototypic flavivirus, yellow fever virus (YFV-17D), differentially interacts w

168 ed mice before and after vaccination against yellow fever virus (YFV-17D).

169 DV, hepatitis C virus, West Nile virus, and yellow fever virus (YFV; vaccine strain 17D) were expres